Samsung jumps into risky but lucrative original drugs market https://t.co/zDLW9p6kTG via @FT
— The Propell Group (@ThePropellGroup) August 22, 2017
#healthtech
Samsung jumps into risky but lucrative original drugs market https://t.co/zDLW9p6kTG via @FT
— The Propell Group (@ThePropellGroup) August 22, 2017
#healthtech